Physician profile
Irving J Fishman
NPI 1700884301
$460.12
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $77.20 · 2021: $79.06 · 2022: $109.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $153.51 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $73.31 | 2019-2021 | |
| Medtronic USA, INC. | $59.12 | 2019-2020 | |
| Neotract INC. | $38.50 | 2020 | |
| Ambu INC. | $37.71 | 2021-2022 | |
| Janssen Biotech, INC. | $28.70 | 2019 | |
| Photocure INC | $25.27 | 2019 | |
| Procept Biorobotics Corporation | $24.01 | 2019 | |
| Axonics, INC. | $19.99 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irving Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.